Non-peptidic CCR1 receptor antagonists in combination with cyclosporin A for the treatment of cardiac graft rejection

摘要

This invention is directed to pharmaceutical compositions useful in treating heart transplant rejection in mammals comprising a pharmaceutically acceptable excipient, a therapeutically effective amount of a non-peptide CCR1 receptor antagonist and a sub-nephrotoxic amount of cyclosporin A.